Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy
Completed · Not applicable
Conditions studied: Traumatic Brain Injury, Fatigue
In brief
This study aims to evaluate the efficacy of 4 weeks of daily light exposure in reducing Post-Traumatic Brain Injury (TBI) Fatigue immediately post-treatment and at a one-month follow up. The investigators hypothesize that individuals receiving 4 weeks of bright white light treatment will report significant reductions in fatigue compared to individuals receiving dim red light treatment for the same duration of time, and that these treatment effects will be maintained one month after treatment completion.
Key facts
- Study ID
- NCT01725750
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 88
- Starts
- 2012-11-01
- Expected to finish
- 2017-06-01
- Last updated by the study team
- 2019-08-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Documented TBI of any severity
- At least 6 months post injury
- Presence of clinically significant fatigue, operationalized as a score of 22 or more on the Multidimensional Assessment of Fatigue
- Age 18 or older
- English speaking
You may not qualify if…
- Neurological disease other than TBI
- Pregnancy (because of pregnancy fatigue)
- Medical illness causing fatigue, such as anemia, hypothyroidism, HIV, renal failure, cirrhosis or cancer treatment in the past year
- Current major depressive episode or substance abuse
- Diagnosed sleep disorder or high risk for sleep apnea
- History of bipolar disorder or manic or hypomanic episodes
- Current chronic, severe headaches
- Sensitivity to bright light
- History of retinal damage or disease
Where it is running
- The Brain Injury Research Center at Icahn School of Medicine at Mount Sinai — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.